Viga Delay Spray For Men Enhance Sexual Stamina Buy Online 03055997199
Powerful sex long time delay spray for men. 100% Pure
original & imported from different countries e.g. Germany, USA & England
It will give you maximum power and timing and excellent result
guaranteed.
Advantages of Viga Spray in Pakistan:
1. Guaranteed increase your sexual stamina and ejaculation
timing up to 30 to 45 minutes.
2. Better satisfaction of your partner.
3. Give Long enjoyment to both partners.
4. Very fast action and effect within 10 minutes after
applying guaranteed
5. No any side effect.
6. Easy to use or apply
7. It will start working within 10 minutes after apply
8. Give you more confidence
“A Viga Delay sprayin Pakistan helping men last six times longer in bed has been developed by
British doctors,” The Sun reported. It said that tests showed the spray
increased intercourse from seconds to almost four minutes. The newspaper said a
study of 300 men with premature ejaculation used either the spray or a placebo
five minutes before sex. Men who used the spray prolonged intercourse from 0.6
minutes to 3.8 minutes, while the placebo group increased to 1.1 minutes.
The men in this study all had lifelong premature ejaculation
and the Viga spray in Pakistan would not necessarily have the same effect on
men without the condition who simply want sex to last longer. The drug is also
not “spray-on Viagra”, as it contains different drugs and, unlike Viagra, is
not used to treat erectile dysfunction. Further randomized controlled trials
are needed to determine whether the Viga Delay spray in Pakistan does have
advantages over other treatments, such as behavioral or other drug therapies.
Where did the story come from about Viga Delay Spray in Pakistan?
Dr W Wallace Dins more from Royal Victoria Hospital, Belfast
and Michael G Wyllie from Plethora Solutions Ltd (the company that makes the
Viga Delay spray in Pakistan) were co-authors of this study. No sources of
funding are reported, one author is a director and shareholder of Plethora Solutions
Ltd, while the other is a consultant and investigator for the company. The
study was published in the peer-reviewed medical journal BJU International.
What kind of scientific study was about Viga Delay Spray in Pakistan?
This was a double-blind randomized placebo controlled trial.
Its aim was to examine the effects of the Viga Delay Spray in Pakistan on
length of intercourse (ejaculatory latency) in men with premature ejaculation.
The Viga Delay Spray in Pakistan contained 45ml in one pack.
The researchers say that although anesthetic creams are
already successfully used to increase intercourse length, they are not
specifically designed or licensed for this use and have several shortcomings
including mess, a potentially long waiting time and need to use a condom.
The researchers enrolled adult men over 18 years old from 31
centers in Europe (the Czech Republic, Poland, UK and Hungary).
All the men
were in stable heterosexual monogamous relationships and had been diagnosed
with lifelong premature ejaculation according to standard criteria. These
criteria defined lifelong premature ejaculation as “a male sexual dysfunction characterized
by ejaculation, which always or nearly always occurs prior to or within about
one minute of vaginal penetration, an inability to delay ejaculation on all or
nearly all vaginal penetrations, and negative personal consequences, such as
distress, bother, frustration and avoidance of sexual intimacy”.
Men who had erectile dysfunction were excluded from the
study. The researchers also excluded men (or their partners) with physical or
psychological problems that would interfere with the study. They also
disallowed anyone taking antidepressants for conditions other than premature
ejaculation and where the dose had been changed in the last four weeks or was
going to be changed during the study period. Men with alcohol or drug abuse, a
known sensitivity to local anesthetics, those who had pregnant partners or
partners not willing to use contraception during the study, those using certain
heart medications, and those with specific medical conditions or medication
that would increase risk of safety concerns, were also excluded.
When they enrolled, the participants had a medical
examination including heart monitoring, and filled in standard questionnaires
about their premature ejaculation, including the Index of Premature Ejaculation
(IPE), which includes scores for ejaculatory control and sexual satisfaction,
and Premature Ejaculation Profile (PEP). They also rated their orgasms on a five-point
scale from ‘very poor’ to ‘very good’.
The 300 men who reported that they ejaculated within one
minute of beginning intercourse (from penetration to ejaculation) on at least
two out of three occasions in a four-week screening period were randomly assigned
to either a placebo spray or the Viga Delay Spray in Pakistan. The men were
instructed to apply the spray onto the penis five minutes before sex and record
with a stopwatch how long intercourse lasted on each occasion and any adverse
effects. The men were told not to use the spray more than once every 24 hours
and not engage in activity that led to ejaculation for at least 24 hours before
using the spray. The men were also not allowed to use condoms so that
researchers could assess any possible effects of the spray on the men’spartners.
The participants continued to use the sprays under double
blind conditions (neither the participants nor the researchers knew which spray
they were using) for three months. The men filled in the IPE and PEP questionnaires
at monthly clinic visits. At the end of the study, they also rated their
orgasms on the five-point scale used at the start of the study, rated the
sprays on a four-point scale from ‘poor’ to ‘excellent’ and had their penises
examined. The researchers compared the results for the Viga Delay Spray inPakistan and the placebo spray.
What were the results of the study about Viga Delay Spray in Pakistan?
During the study, 18 patients withdrew from the Viga DelaySpray group (out of 200 people) and four withdrew from the placebo group (out
of 100 people), mostly due to withdrawal of consent. This left 278 men with an
average age of 35 years for analysis.
At the start of the study, men reported that intercourse
lasted on average 0.6 minutes. Over the three-month study period, both groups
of men reported an increase in the average length of intercourse, but this
increase was greater in the Viga Delay Spray group: 3.8 minutes in the Viga
Delay Spray treatment group and 1.1 minutes in the placebo group. This represented
a 6.3 fold increase with Viga Delay Spray in Pakistan and a 1.7 fold increase
with placebo.
Men using the Viga Delay Spray in Pakistan reported greater
increases in their ejaculatory control and sexual satisfaction on the Index of
Premature Ejaculation questionnaire than those on placebo. At the end of the
study, two-thirds (66%) of men in the Viga Delay Spray group rated their spray
as ‘excellent’ or ‘good’, compared with 15% in the placebo group.
There were no serious adverse events but about 3% of men and
3% of their partners in the Viga Delay Spray group and 1% of men in the placebo
group reported adverse events that were judged to be treatment-related. None of
the partners of the men in the placebo group reported adverse events. The most
common adverse events in the Viga Delay Spray group included redness of the
genitals, loss of erection, and a burning sensation in the genitals in their
partners.
What interpretations did the researchers draw from these results of Viga Delay Spray in Pakistan?
The researchers concluded that Viga Delay Spray in Pakistan ejaculation
and improved control of ejaculation. They say it improved sexual satisfaction
in men with premature ejaculation and appears to be well tolerated. They
conclude, “Viga Delay Spray in Pakistan therefore appears to offer significant
advantages over other therapies in development for the treatment of [premature
ejaculation].”
What does the NHS Knowledge Service make of this study about Viga Delay Spray in Pakistan?
This study indicates that the Viga Delay Spray in Pakistan can
delay ejaculation in men with lifelong premature ejaculation. Its strengths
include its relatively large size, randomized design, and use of double
blinding and a placebo control group. There are a number of points to note:
This study included only men with a lifelong diagnosis of
premature ejaculation and the results may not be representative of what would
occur in men who have only occasional premature ejaculation or just want to
delay ejaculating.
Although there was a placebo control group, men may have
been able to guess which treatment they were using, as the Viga Delay Spray in Pakistan contains local anesthetics and is likely to produce a numbing
sensation. If the participants guessed which spray they were using, this could
affect their rating of their sexual satisfaction and ejaculatory control.
USAGE: How to Use Viga Delay Spay in Pakistan
Apply 10 Minutes before sexual activity at half length of pains.
From Front Cap to Center of pains.
Note about Delivery about Viga Spray in Pakistan:
1. All products will deliver with complete high privacy in
plain packing all over in Pakistan.
2. If there is other privacy issue then you can collect your
parcel by self from nearest branch or
Office of leopard courier’s services or Daewoo cargo
service.
No comments:
Post a Comment